HDRVX
Price
$21.03
Change
+$0.03 (+0.14%)
Updated
Jul 9 closing price
Net Assets
311.64M
HFQRX
Price
$8.03
Change
+$0.02 (+0.25%)
Updated
Jul 9 closing price
Net Assets
7.55B
Interact to see
Advertisement

HDRVX vs HFQRX

HDRVX vs HFQRX Comparison Chart in %
View a ticker or compare two or three
VS
HDRVX vs. HFQRX commentary
Jul 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HDRVX is a Hold and HFQRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.55B vs. HDRVX (312M). HFQRX pays higher dividends than HDRVX: HFQRX (6.36) vs HDRVX (1.95). HDRVX was incepted earlier than HFQRX: HDRVX (11 years) vs HFQRX (11 years). HDRVX (0.99) is less costly to investors than HFQRX (0.69). HFQRX is a more actively managed with annual turnover of: 175.00 vs. HDRVX (50.00). HDRVX (1000000) and HFQRX (1000000) have matching initial minimum investment requirements. HFQRX annual gain was more profitable for investors over the last year : 24.19 vs. HDRVX (17.82). HFQRX return over 5 years is better than : 71.09 vs. HDRVX (63.98).
HDRVXHFQRXHDRVX / HFQRX
Total Expense Ratio0.770.69112%
Annual Report Gross Expense Ratio0.990.69143%
Fund Existence11 years11 years-
Gain YTD16.93413.841122%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets312M7.55B4%
Annual Yield % from dividends1.956.3631%
Returns for 1 year17.8224.1974%
Returns for 3 years61.2568.6189%
Returns for 5 years63.9871.0990%
Returns for 10 years134.25129.99103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TILHX30.55N/A
N/A
Nuveen Large Cap Growth I
PMVQX32.95N/A
N/A
PGIM Quant Solutions Mid-Cap Val R6
WCMGX36.96N/A
N/A
First Trust WCM Focused Global Gr Inst
MSOOX20.64N/A
N/A
MassMutual Small Cap Opps I
EEMGX12.30N/A
N/A
MFS Emerging Markets Equity Research R4